ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
01 1ChemWerth Inc
02 1LGM Pharma
03 2Dr. Reddy's Laboratories
04 1Jai Radhe Sales
05 1HRV Global Life Sciences
06 1TAPI Technology & API Services
07 1Actavis Inc
08 1Almelo
09 2Amino Chemicals
10 2Apotex Pharmachem
11 1Aspire Lifesciences Pvt Ltd
12 1Aurobindo Pharma Limited
13 1Chromo Laboratories
14 1Hetero Drugs
15 1Jiangsu Nhwa Pharmaceutical
16 1Jubilant Generics
17 1Lupin Ltd
18 2Macleods Pharmaceuticals Limited
19 1Megafine Pharma (P) Limited
20 1Qilu Tianhe Pharmaceutical Co., Ltd.
21 1RANBAXY LABORATORIES LIMITED
22 1Raks Pharma
23 1Ramdev Chemicals Pvt Ltd
24 1Shodhana Laboratories Pvt. Ltd
25 1Synergene Active Ingredients Pvt Ltd
26 1Unipex
27 1Wockhardt
28 2Zydus Lifesciences
01 2Canada
02 2China
03 1France
04 22India
05 1Ireland
06 1Israel
07 2Malta
08 2U.S.A
01 14Active
02 7Inactive
03 12Blank
01 6Valid
02 1Withdrawn by Holder
03 26Blank
01 33Blank
01 1WC-0023
02 1WC-0039
03 2WC-0079
04 1WC-0084
05 1WC-0087-(Annexure-1)
06 1WC-0201
07 1WC-0317A2
08 1WC-092
09 1WC-390A4
10 23Blank
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17922
Submission : 2004-12-23
Status : Active
Type : II
Date of Issue : 2022-09-30
Valid Till : 2025-11-30
Written Confirmation Number : WC-390A4
Address of the Firm :
NDC Package Code : 55111-801
Start Marketing Date : 2004-12-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19005
Submission : 2005-12-07
Status : Inactive
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21147
Submission : 2007-12-17
Status : Active
Type : II
Date of Issue : 2022-06-06
Valid Till : 2025-07-07
Written Confirmation Number : WC-0039
Address of the Firm :
NDC Package Code : 55111-801
Start Marketing Date : 2004-12-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19503
Submission : 2006-05-30
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-02-27
Pay. Date : 2016-12-27
DMF Number : 31183
Submission : 2016-12-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18042
Submission : 2005-01-31
Status : Inactive
Type : II
We have 28 companies offering Ziprasidone Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?